The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of CA-4948, a novel inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK4) in patients (pts) with r/r non-Hodgkin lymphoma.
 
Allison Claire Rosenthal
Employment - Allergan (I)
 
Han W. Tun
Research Funding - Bristol-Myers Squibb; Celgene; Spectrum Pharmaceuticals
 
Anas Younes
Honoraria - Abbvie; Janssen; Merck; Roche; Takeda
Research Funding - AstraZeneca (Inst); Curis (Inst); Genentech (Inst); Janssen (Inst); Pharmacyclics (Inst); Roche (Inst)
 
Grzegorz S. Nowakowski
Consulting or Advisory Role - Celgene (Inst); Genentech (Inst); MorphoSys (Inst)
Research Funding - Celgene (Inst); MorphoSys (Inst); NanoString Technologies (Inst)
 
Matthew Alexander Lunning
Consulting or Advisory Role - Abbvie; Bayer; Celgene; Genentech; Genzyme; Gilead Sciences; Janssen Oncology; Juno Therapeutics; Kite, a Gilead company; Novartis; Pharmacyclics; Portola Pharmaceuticals; Seagen; Spectrum Pharmaceuticals; TG Therapeutics; Verastem
Research Funding - Celgene (Inst); Celgene (Inst); Celgene (Inst); Curis (Inst); Janssen Oncology (Inst); Juno Therapeutics (Inst); Juno Therapeutics (Inst); miRagen (Inst); TG Therapeutics (Inst); TG Therapeutics (Inst)
 
Krish Patel
Honoraria - Dava Oncology
Consulting or Advisory Role - AstraZeneca; Celgene; Genentech; Juno Therapeutics; Sunesis Pharmaceuticals; Verastem
Speakers' Bureau - AstraZeneca; Genentech; Pharmacyclics/Janssen
Research Funding - Aptevo Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Curis (Inst); MEI Pharma (Inst); Pharmacyclics (Inst); Sunesis Pharmaceuticals (Inst); Takeda (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - MEI Pharma
 
Daniel Jeffrey Landsburg
Consulting or Advisory Role - Celgene; Curis
Research Funding - Curis; Curis (Inst); Takeda (Inst); Triphase Accelerator Corp (Inst)
 
Robert E. Martell
Employment - Curis
Leadership - Curis
Stock and Other Ownership Interests - Curis
Consulting or Advisory Role - cyteir
 
Lori Ann Leslie
Speakers' Bureau - Celgene; Seagen